SignatureFD’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43K Hold
85
﹤0.01% 3205
2026
Q1
$1.01K Buy
+85
New +$1.22K ﹤0.01% 3208
2025
Q4
Sell
-268
Closed -$5.8K 3523
2025
Q3
$5.8K Buy
268
+17
+7% +$379 ﹤0.01% 2615
2025
Q2
$5.58K Sell
251
-874
-78% -$19.4K ﹤0.01% 2573
2025
Q1
$26.7K Buy
1,125
+28
+3% +$663 ﹤0.01% 1910
2024
Q4
$23.2K Buy
1,097
+642
+141% +$16.8K ﹤0.01% 1994
2024
Q3
$14.7K Sell
455
-47
-9% -$1.39K ﹤0.01% 2184
2024
Q2
$11.9K Buy
502
+493
+5,478% +$12.7K ﹤0.01% 2194
2024
Q1
$268 Hold
9
﹤0.01% 3074
2023
Q4
$288 Sell
9
-1,891
-100% -$54.9K ﹤0.01% 3027
2023
Q3
$55.6K Buy
+1,900
New +$68.3K ﹤0.01% 1340
2023
Q2
Sell
-7
Closed -$241 3354
2023
Q1
$241 Buy
+7
New +$227 ﹤0.01% 3172
2022
Q4
Sell
-1,850
Closed -$43K 3400
2022
Q3
$43K Buy
+1,850
New +$59.1K ﹤0.01% 1346
2022
Q2
Sell
-1,175
Closed -$65K 3324
2022
Q1
$65K Hold
1,175
﹤0.01% 1244
2021
Q4
$63K Buy
+1,175
New +$54.5K ﹤0.01% 1231
2020
Q3
Sell
-78
Closed -$1K 2745
2020
Q2
$1K Buy
+78
New +$855 ﹤0.01% 2374

Other funds holding SGRY

SignatureFD's SGRY Position: Q2 2026 in Review

SignatureFD held its Surgery Partners (SGRY) position steady in Q2 2026 at 85 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #3205.

SignatureFD first reported a position in SGRY in Q2 2020 and has held it in 16 quarters since. The position peaked at $65K in Q1 2022. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • SignatureFD held 85 shares of Surgery Partners worth $1.43K as of Q2 2026.
  • SignatureFD left its Surgery Partners share count unchanged in Q2 2026.
  • Surgery Partners made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3205 holding.
  • SignatureFD first reported a position in Surgery Partners in Q2 2020 and has held it in 16 quarters since.
  • SignatureFD's Surgery Partners position peaked at $65K in Q1 2022.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.